Drug lookup
Drug reference

Penicillin G

Penicillin · Antibacterial

Also known as Benzylpenicillin, Penicillin G Sodium, Penicillin G Potassium

PenicillinAntibacterialATC J01CE01
CDSCO approvedSchedule HJan AushadhiATC J01CE01
Pharmacokineticsplasma · t hours
23minONSET23minPEAK40min5hDURATION
ONSET
23min · Rapid (minutes for IV, 15-30 minutes for IM).
PEAK
23min · End of infusion (IV), 15-30 minutes (IM).
40min · Approximately 20-60 minutes (in adults with normal renal function).
DURATION
5h · 4-6 hours (due to rapid elimination).
EXCRETION
not curated
INTERACTIONS
2 major
incl. contraindicated
PREGNANCY
B
FDA category + note
Top interactionssee all 10
  • AminophyllineContraindicatedTextbookKDT 7e · p227
  • MethotrexateSevereDatabaseDDInter

Mechanism

Penicillin G inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) located inside the bacterial cell wall. This binding prevents the cross-linking of peptidoglycan chains, which is essential for maintaining the integrity and rigidity of the cell wall. The resulting defective cell wall leads to increased osmotic pressure, cell lysis, and ultimately bacterial death.

Indications

Streptococcal infections (e.g., pharyngitis, endocarditis, pneumonia)Syphilis (all stages)DiphtheriaClostridial infections (e.g., tetanus, gas gangrene)Meningococcal meningitisPneumococcal pneumoniaAnthraxListeria monocytogenes infectionsRat-bite feverActinomycosisRheumatic fever prophylaxis (off-label)Prophylaxis for rheumatic fever (to prevent infection by group A streptococci)Serious infections sensitive to penicillin (fewer than 5% of isolates)

Dosing

Adult
IV/IM for moderate to severe infections: 2 to 4 million units (MU) every 4 to 6 hours. IV for severe infections (e.g., meningitis, endocarditis): 18 to 24 MU per day, administered in divided doses every 4 to 6 hours or as a continuous infusion. IM for Syphilis (early): Benzathine Penicillin G 2.4 MU single dose.…
Pediatric
Neonates (0-7 days): 25,000 to 50,000 units/kg/dose IV/IM every 8 to 12 hours. Infants (7-28 days): 50,000 units/kg/dose IV/IM every 6 to 8 hours. Children (1 month and older): 100,000 to 250,000 units/kg/day IV/IM divided every 4 to 6 hours, depending on infection severity.
Renal adjustment
CrCl >50 mL/min: No adjustment. CrCl 10-50 mL/min: Administer usual dose every 6-8 hours. CrCl <10 mL/min: Administer usual dose every 8-12 hours. Hemodialysis: Administer dose after dialysis.
Hepatic adjustment
Generally no specific dose adjustment required.
Geriatric
Monitor renal function closely and adjust dose based on CrCl. No specific age-related dose reduction beyond renal considerations.
Max dose
Typically 24 million units/day (IV) for adults, though higher doses have been used in specific severe infections with careful monitoring.

Pharmacokinetics

Onset
Rapid (minutes for IV, 15-30 minutes for IM).
Peak effect
End of infusion (IV), 15-30 minutes (IM).
Duration
4-6 hours (due to rapid elimination).
Half-life
Approximately 20-60 minutes (in adults with normal renal function).
Bioavailability
Poor (approximately 15-30%) when administered orally due to acid instability; primarily given via IM or IV route.
Protein binding
45-65%.
Metabolism
Minimal hepatic metabolism; approximately 10-30% is metabolized to penicilloic acid.
Excretion
Primarily renal (60-90% excreted unchanged in urine by glomerular filtration and tubular secretion within 4 hours).

Contraindications

  • History of severe hypersensitivity reaction to penicillin (e.g., anaphylaxis, Stevens-Johnson syndrome)
  • History of severe allergic reaction to other beta-lactam antibiotics (e.g., cephalosporins, carbapenems) due to potential cross-reactivity

Side effects

Common
Rash (maculopapular, urticarial)DiarrheaNausea, vomitingOral candidiasis (thrush)Vaginal candidiasisPain, induration, or sterile abscess at IM injection siteFeverHypersensitivity reactionsGastrointestinal side effects (e.g., diarrhea)
Serious
  • Anaphylaxis (rare but life-threatening hypersensitivity reaction)
  • Seizures (especially with high doses or renal impairment)
  • Clostridioides difficile-associated diarrhea (CDAD)/Pseudomembranous colitis
  • Interstitial nephritis
  • Hemolytic anemia
  • Leukopenia, thrombocytopenia
  • Serum sickness-like reaction
  • Jarisch-Herxheimer reaction (in syphilis treatment)
  • Hyperkalemia (with potassium penicillin G in high doses)
  • Hypersensitivity reactions (rash to anaphylaxis)
  • Serum sickness
  • Stevens-Johnson syndrome
  • Nephropathy
  • Hematologic reactions (neutropenia, prolonged use)
  • Neurotoxicity (seizure, high doses, renal impairment)

Pregnancy & lactation

Pregnancy

B

Lactation

Excreted in small amounts into breast milk. Generally considered compatible with breastfeeding, but monitor infant for potential adverse effects (e.g., diarrhea, candidiasis, allergic reaction).

Drug interactions

Aminophylline
Contraindicated
Textbook

Should not be mixed in the same infusion bottle/syringe.

Do not mix.

Source: KDT 7e · p227

Methotrexate
Severe
Database

Drug interaction classified as: excretion

Source: DDInter

Azithromycin
Moderate
Textbook-cited

Reduced antibacterial efficacy; therapeutic failure

Avoid concurrent use of bacteriostatic and bactericidal antibiotics

Source: KDT 7e · p949

Chloramphenicol
Moderate
Textbook-cited

Reduced antibacterial efficacy; therapeutic failure

Avoid concurrent use of bacteriostatic and bactericidal antibiotics

Source: KDT 7e · p949

Clarithromycin
Moderate
Textbook-cited

Reduced antibacterial efficacy; therapeutic failure

Avoid concurrent use of bacteriostatic and bactericidal antibiotics

Source: KDT 7e · p949

Clindamycin
Moderate
Textbook-cited

Reduced antibacterial efficacy; therapeutic failure

Avoid concurrent use of bacteriostatic and bactericidal antibiotics

Source: KDT 7e · p949

Doxycycline
Moderate
Textbook-cited

Reduced antibacterial efficacy; therapeutic failure

Avoid concurrent use of bacteriostatic and bactericidal antibiotics

Source: KDT 7e · p949

Erythromycin
Moderate
Textbook-cited

Reduced antibacterial efficacy; therapeutic failure

Avoid concurrent use of bacteriostatic and bactericidal antibiotics

Source: KDT 7e · p949

Minocycline
Moderate
Textbook-cited

Reduced antibacterial efficacy; therapeutic failure

Avoid concurrent use of bacteriostatic and bactericidal antibiotics

Source: KDT 7e · p949

Tetracycline
Moderate
Textbook-cited

Reduced antibacterial efficacy; therapeutic failure

Avoid concurrent use of bacteriostatic and bactericidal antibiotics

Source: KDT 7e · p949

2 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.

Related guidelines

Other Penicillin drugs

Ask House about Penicillin G

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e, Harrison 22e, Katzung·Verified: 2026-05-13 · House clinical team